Candida albicans biofilm inhibition by synergistic action of terpenes and fluconazole

Indian Journal of Experimental Biology

Volumn 51, Issue 11, 2013, Pages 1032-1037

  Pemmaraju, Suma C ^a   Pruthi, Parul A ^a   Prasad, R ^a   Pruthi, Vikas ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Antifungal therapy; Biofilm; C andida albicans; Terpenes

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; TERPENE;

ARTICLE; BIOFILM; CANDIDA ALBICANS; DRUG EFFECT; DRUG POTENTIATION; SCANNING ELECTRON MICROSCOPY;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; DRUG SYNERGISM; FLUCONAZOLE; MICROSCOPY, ELECTRON, SCANNING; TERPENES;

EID: 84887534000     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Douglas LJ, Candida biofilms and their role in infection, Trends Microbiol, 11 (2003) 30.
2. Eraso E, Moragues MD, Villar-Vidal M, Sahand IH, González-Gómez N, Pontón J & Quindós G, Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species, J Clin Microbiol, 44 (2006) 3340.
3. Kojic EM & Darouiche RO, Candida infections of medical devices, Clin Microbiol Rev, 17 (2004) 255.
4. Zhang AY, Camp WL & Elewski BE, Advances in topical and systemic antifungals, Dermatol Clin, 25 (2007) 165.
5. Alexander BD & Perfect JR, Antifungal resistance trends towards the year 2000: Implications for therapy and new approaches, Drugs, 54 (1997) 657.
6. Singh N, Nayyar A, Bhattacharjee G, Singh AK & Pruthi V, Assessment of dentifrices against Candida biofilm, Appl Biochem Biotech, 167 (2012) 1688.
7. Marcos-Arias C, Eraso E, Madariaga L & Quindós G, In vitro activities of natural products against oral Candida isolates from denture wearers, BMC Complement Alternat Medi, 11 (2011) 119.
8. Tampieri MP, Galuppi R, Macchioni F, Carelle MS, Falcioni L, Cioni PL & Morelli I, The inhibition of Candida albicans by selected essential oils and their major components, Mycopathologia, 159 (2005) 339.
9. Mansouri MD & Darouiche RO, In vitro activity and in vivo efficacy of catheters impregnated with chloroxylenol and thymol against uropathogens, Clin Microbiol Infect, 14 (2008) 190.
10. He M, Du M, Fan M & Bian Z, In vitro activity of eugenol against Candida albicans biofilms, Mycopathologia, 163 (2007) 137.
11. Hammer KA, Carson CF & Riley TV, Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil, J Appl Microbiol, 95 (2003) 853.
12. Barchiesi F, Silvestri C, Arzeni D, Ganzetti G, Castelletti S, Simonetti O, Cirioni O, Kamysz W, Kamysz E, Spreghini E, Abruzzetti A, Riva A, Offidani AM, Giacometti A & Scalise G, In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents, Med Mycol, 47 (2009) 321.
13. Wayne PA, Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27-A3 and Supplement S3, 3rd edition. CLSI (USA) 2010.
14. Wei G, Xin Xu X, & Wu CD, In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures, Arch Oral Biol, 56 (2011) 565.
15. Agarwal V, Lal P & Pruthi V, Prevention of Candida albicans biofilm by plant oils, Mycopathologia, 165 (2008) 13.
16. Palmeira de Oliveira A, Salgueiro L, Palmeira de Oliveira R, Martinez de Oliveira J, Pina Vaz C, Queiroz JA & Rodrigues AG, Anti-Candida activity of essential oils, Mini-Rev Med Chem, 9 (2009) 1292.
17. Hammer KA, Carson CF & Riley TV, Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans, Med Mycol, 38 (2000) 355.
18. Pauli A, Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils, Med Res Rev, 26 (2006) 223.
19. Ahmad A, Khan A, Akhtar F, Yousuf S, Xess I, Khan L A & Manzoor N, Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida, Eur J Clin Microbiol Infect Dis, 30 (2011) 41.
20. Braga PC, Culici M, Alfieri M & Dal Sasso M, Thymol inhibits Candida albicans biofilm formation and mature biofilm, Int J Antimicrob Ag, 31 (2008) 472.
21. De Nollin S & Borgers M, Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole, Antimicrob Agents Chemother, 7 (1975) 704.
22. Bailey EM, Krakovsky DJ & Rybak MJ, The triazole antifungal agents: a review of itraconazole and fluconazole, Pharmacotherapy, 10 (1990) 146.
23. Ahmad A, Khan A, Khan LA & Manzoor N, In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates, J Med Microbiol, 59 (2010) 1178.
24. Chami F, Chami N, Bennis S, Trouillas J & Remmal A, Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model, J Antimicrob Chemother, 54 (2004) 909.
25. Dalleau S, Cateau E, Bergés T, Berjeaud J & Imbert C, In vitro activity of terpenes against Candida biofilms, Int J Antimicrob Ag, 31 (2008) 572.
26. Bakkali F, Averbeck S, Averbeck D & Idaomar M, Biological effects of essential oils-a review, Food Chem Toxicol, 46 (2008) 446.
27. Traboulsi RS, Mukherjee PK & Ghannouma MA, In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients, Int J Antimicrob Ag, 31 (2008) 272.